Skip to main content
All lobbying filings

MEHLMAN CONSULTING, INC.

Lobbying for ASSOCIATION OF ACCESSIBLE MEDICINES · Trade Association

 Filing 3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • JOSEPH EDWARD BROWN III New on this filing
    Previously held: Sr Prof Staff (EPW Comm Maj/Sen. Moore Capito); Prof Staff (EPW Comm Min/Ranking Mem Sen. Moore Capito); Leg Asst (Sen. Boozman); Maj Leg Asst (EPW Comm Maj/Sen. Jim Inhofe); Maj Research Asst (EPW Comm Maj/Sen. Jim Inhofe); Intern (Rep. Jim Renacci)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 7
  • S 1040
    Drug Competition Enhancement Act
  • HR 5526
    Biosimilar Red Tape Elimination Act
  • S 1954
    Biosimilar Red Tape Elimination Act
  • HR 3269
    ETHIC Act
  • S 43
    Skinny Labels, Big Savings Act
  • HR 1843
    To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
  • S 1302
    Increasing Transparency in Generic Drug Applications Act
 Lobbying activity 3
Medicare/Medicaid

Issues related to generic medicines.

Health Issues

Issues related to generic medicines. issues related to generic and biosimilar medications.

Pharmacy

Issues related to pharmaceutical manufacturing supply chain. S. 1040 - Drug Competition Enhancement Act; H.R. 5526/S. 1954 -Biosimilar Red-tape Elimination Act; H.R. 3269 - ETHIC Act; S. 43 - Skinny Labels, Big Savings Act; H.R. 1843/S. 1302- Increasing Transparency in Generic Drug Applications Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem